FDA OKs Drug for Cholestatic Pruritus in Alagille Syndrome
Odevixibat is indicated for treatment of cholestatic pruritus associated with Alagille syndrome in patients as young as 12 months. It marks the second indication for the drug.
Source: medscape.com